PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

Data from REAL-PE analysis demonstrated only 0.5% of all PE patients received catheter based therapy

Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism
2024-05-03
(Press-News.org) Long Beach, Calif. – May 3, 2024 – New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive therapy compared to men or non-Black patients. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

                                                                                                            

PE is often caused by blood clots in the legs, otherwise known as deep vein thrombosis, that travel through the veins and into the lungs. PE affects around 900,000 people in the U.S. each year, with 10-30% dying within one month of diagnosis. Ultrasound-assisted catheter-directed thrombolysis (USCDT), a common invasive treatment option for PE, enables deeper penetration of the clot-busting medication into the clot, restoring normal blood flow faster. Mechanical thrombectomy (MT), another invasive treatment method has been shown to reduce thrombus burden and pulmonary artery pressure (PAP) and to improve right ventricular (RV) function in patients with high-risk or intermediate-high-risk PE.

 

REAL-PE analyzed data from patients within the Truveta database diagnosed with PE and treated with USCDT or MT for PE. Patient characteristics including race, ethnicity, age, sex, comorbidities, and prior diagnoses were assessed to investigate their association with the type of treatment used. Of the more than 430,000 patients diagnosed with PE, about 2,000 patients analyzed were treated with one of the invasive therapies. Women or Black patients were less frequently treated with invasive therapy than men or non-Black patients. Moreover, women more than men and Black people more than white people had higher bleeding rates.

 

“Although this data demonstrates the value of real-world data in the assessments of new technologies in which randomized data are not always available, there is still work that needs to be done to evaluate the current utilization of advanced therapies for PE in underrepresented patient populations,” said Sahil A. Parikh, MD, Associate Professor of Medicine, Columbia University Irving Medical Center, and lead author of the study. “Evaluating care disparities in real clinical practices is key to addressing the existing barrier and improving patient outcomes.”

 

Session Details:

“Disparities in Pulmonary Embolism Care: Insights from Big Data Analytics” Friday, May 3, 2024; 2:02-2:09 PM PT Long Beach Convention Center, 104A, First Level  

###

 

About Society for Cardiovascular Angiography & Interventions (SCAI)

 

The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 4,500 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit https://scai.org/.

 

For more information about the SCAI 2024 Scientific Sessions, visit https://scai.org/scai-2024-scientific-sessions. Follow @SCAI on X (formerly Twitter) and on LinkedIn for the latest heart health news and use #SCAI2024 to follow the latest discussions.

 

END


[Attachments] See images for this press release:
Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism 2

ELSE PRESS RELEASES FROM THIS DATE:

Pilot program improves well-being of families during advanced care planning

2024-05-03
WASHINGTON (May 3, 2024) – Children with life-limiting rare diseases and their caregivers face tremendous stress and anxiety about the heart-breaking decisions before them. A new intervention – designed at Children’s National Hospital to support the palliative needs of these families – improved their spiritual and emotional well-being, according to new research published in the journal, Pediatrics.    Called FACE Rare (FAmily CEntered Pediatric Advance Care Planning Intervention for Rare Diseases), the counseling tools were found to be safe, effective and increased feelings of peace among families in this underserved ...

The key role of Galectin-3 in brain tumour development

2024-05-03
A research group at the Department of Biochemistry and Molecular Biology of the University of Seville has made a significant advance by discovering the crucial role of the protein Galectin-3 in the progression of various types of brain tumours. In these tumours, the most abundant immune system cells, microglia and macrophages, overexpress Galectin-3, which creates an immunosuppressed environment which inhibits the action of other immune cells against cancer cells. In vitro findings have shown that specific inhibition of Galectin-3 in microglial cells promotes expression of proinflammatory markers and reverses the presence of key immunosuppressive ...

Announcing Junevity as Tier 3 Sponsor of ARDD 2024

Announcing Junevity as Tier 3 Sponsor of ARDD 2024
2024-05-03
The University of Copenhagen is excited to announce Junevity as a Tier 3 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online. Junevity is rewinding diseases of aging with novel transcription factor medicines. Based on 6 years of breakthrough research at UCSF, Junevity's REWINDTM platform identifies new targets based on large-scale genomics, machine learning, and cell aging experiments. Junevity is advancing multiple therapeutic programs towards ...

Climate change amplifies severity of combined wind-rain extremes over the UK and Ireland

2024-05-03
Climate change will cause an increase in extreme winter storms combining strong winds and heavy rainfall over the UK and Ireland, new research has shown. The new study was led by experts at Newcastle University and the Met Office and investigated how future climate change may influence compound wind-rain extremes, which are events where extreme wind and rainfall occur simultaneously. The researchers analysed data from climate simulations covering control (1981-2000) and future (2060-2081) periods, ...

Exeter announces new £3.4 million global funding for solutions to antifungal drug resistance

Exeter announces new £3.4 million global funding for solutions to antifungal drug resistance
2024-05-03
Researchers working on solutions for antifungal resistance are being encouraged to apply to a new £3.4 million fund led by the University of Exeter with UK government funding. The new fund, called FAILSAFE (Fungal AMR Innovations for LMICS: Solutions and Access For Everyone), is being launched by the University of Exeter’s MRC Centre for Medical Mycology, in partnership with the UK Department of Health and Social Care’s Global AMR Innovation Fund (GAMRIF). Life-threatening fungal diseases take as many lives annually as TB or malaria, but the organisms ...

In medieval England, leprosy spread between red squirrels and people, genome evidence shows

2024-05-03
Evidence from archaeological sites in the medieval English city of Winchester shows that English red squirrels once served as an important host for Mycobacterium leprae strains that caused leprosy in people, researchers report May 3 in the journal Current Biology. “With our genetic analysis we were able to identify red squirrels as the first ancient animal host of leprosy,” says senior author Verena Schuenemann of the University of Basel in Switzerland. “The medieval red squirrel strain we recovered is more closely related to medieval human strains from the same city than to strains isolated from infected ...

Source of pregnancy complications from infections revealed by placenta map

2024-05-03
The first panoramic view of infection pathways in the human placenta has been created, which could highlight potential drug targets to develop pregnancy-safe therapies for malaria, toxoplasmosis and listeria, all diseases that can cause severe pregnancy complications.     Researchers from the Wellcome Sanger Institute, the University of Cambridge, the University of Dundee, and collaborators, used novel ‘mini placenta’ models to map the placental response to infections in early development. This ...

Lepra in the middle ages: New insights on transmission pathways through squirrels

Lepra in the middle ages: New insights on transmission pathways through squirrels
2024-05-03
Researchers at the University of Basel and the University of Zurich have been able to prove that British squirrels carried leprosy bacteria as early as the Middle Ages. Further results revealed a link between the pathogens found in the medieval rodents and those in the local human population during that period. Skin spots, deformed noses, ulcers: leprosy, is an infectious disease that can bring about some serious symptoms. The bacterium responsible, Mycobacterium leprae, which still infects around 200,000 people each year especially in the Global South, also has a long history in Europe. The international research group led by paleogeneticist Professor Verena Schünemann ...

The Foundational Questions Institute, FQxI, appoints Pinar Emirdag to Board of Directors

The Foundational Questions Institute, FQxI, appoints Pinar Emirdag to Board of Directors
2024-05-03
The Foundational Questions Institute, FQxI, a philanthropically-funded science funding agency and think tank, is delighted to announce that Dr Pinar Emirdag has been appointed to the Institute’s Board of Directors. Emirdag, a financial services executive and entrepreneur, is currently director of Hupomone Ventures, having previously spearheaded industry-changing initiatives at institutions such as JP Morgan, Citi and the London Stock Exchange and at start-ups including Lava Trading and Clearmatics. FQxI’s Chief Operating Officer Kavita ...

Stretchable e-skin could give robots human-level touch sensitivity

Stretchable e-skin could give robots human-level touch sensitivity
2024-05-03
A first-ever stretchy electronic skin could equip robots and other devices with the same softness and touch sensitivity as human skin, opening up new possibilities to perform tasks that require a great deal of precision and control of force. The new stretchable e-skin, developed by researchers at The University of Texas at Austin, solves a major bottleneck in the emerging technology. Existing e-skin technology loses sensing accuracy as the material stretches, but that is not the case with this new version. "Much like human skin has to stretch and bend ...

LAST 30 PRESS RELEASES:

Protective genetic mutation offers new hope for understanding autism and brain development

Colombia's Dr. Natalia Acosta-Baena uncovers critical link between brain development and degeneration

How can we reduce adolescent pregnancies in low- and middle-income countries?

When sun protection begets malnutrition: vitamin D deficiency in Japanese women

Cannabis use can cause chromosomal damage, increasing cancer risk and harming offspring

Survey finds many Americans apply misguided and counterproductive advice to combat holiday weight gain

New study reveals half a century of change on Britain’s iconic limestone pavements

Green flight paths could unlock sustainable aviation, new research suggests

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

[Press-News.org] Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism
Data from REAL-PE analysis demonstrated only 0.5% of all PE patients received catheter based therapy